Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Holding(s) in Company

2 Mar 2011 16:20

RNS Number : 2206C
Akers Biosciences, Inc.
02 March 2011
 



2 March 2011

 

Akers Biosciences Inc.

(the "Company")

 

Holdings in Company

 

Akers Biosciences, Inc (AIM:AKR) was notified on 1 March 2011 that, following a number of recent share disposals, Brittany Capital Management Ltd no longer holds a notifiable interest in the Company.

 

Enquiries:

Akers Biosciences

Thomas A. Nicolette, President and Chief Executive Officer

Tel: + 1 856 848 8698

Daniel Stewart & Company plc (Nomad and Broker)

Antony Legge / Noelle Greenaway

Tel: + 44 (0) 20 7776 6550

M: Communications

Ben Simons

Tel: + 44 (0) 20 7920 2340

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUGUBGWUPGGQP

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.